Nuzenio

About Agomab Therapeutics

About Agomab Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Agomab Therapeutics (Nasdaq: AGMB) raises $208M IPO, funds pipeline to 2029 - Stock TitanStock Titan · Thu, 06 Aug 2026 20:07:36 GMTBelgian company Agomab Therapeutics acquires Spanish biotech Origo Biopharma - ICEX-Invest in SpainICEX-Invest in Spain · Thu, 06 Aug 2026 00:11:07 GMTWe're Not Very Worried About AgomAb Therapeutics' (NASDAQ:AGMB) Cash Burn Rate - MoomooMoomoo · Wed, 05 Aug 2026 16:19:51 GMTWe Think AgomAb Therapeutics (NASDAQ:AGMB) Can Afford To Drive Business Growth - simplywall.stsimplywall.st · Wed, 05 Aug 2026 11:15:37 GMT36,236,779 Common shares of AgomAb Therapeutics NV are subject to a Lock-Up Agreement Ending on 5-AUG-2026. - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 00:22:50 GMTPrice to sales forward of AgomAb Therapeutics NV – NASDAQ:AGMB - TradingViewTradingView · Wed, 29 Jul 2026 07:36:49 GMT

Timeline

Thu, 06 Aug 2026 20:07:36 GMTAgomab Therapeutics (Nasdaq: AGMB) raises $208M IPO, funds pipeline to 2029 - Stock Titan
Thu, 06 Aug 2026 00:11:07 GMTBelgian company Agomab Therapeutics acquires Spanish biotech Origo Biopharma - ICEX-Invest in Spain
Wed, 05 Aug 2026 16:19:51 GMTWe're Not Very Worried About AgomAb Therapeutics' (NASDAQ:AGMB) Cash Burn Rate - Moomoo
Wed, 05 Aug 2026 11:15:37 GMTWe Think AgomAb Therapeutics (NASDAQ:AGMB) Can Afford To Drive Business Growth - simplywall.st
Wed, 05 Aug 2026 00:22:50 GMT36,236,779 Common shares of AgomAb Therapeutics NV are subject to a Lock-Up Agreement Ending on 5-AUG-2026. - marketscreener.com
Wed, 29 Jul 2026 07:36:49 GMTPrice to sales forward of AgomAb Therapeutics NV – NASDAQ:AGMB - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for About Agomab Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.